Rates of Active, Current Epilepsy in U.S. Adults Rising

Share this content:
Rates of Active, Current Epilepsy in U.S. Adults Rising
Rates of Active, Current Epilepsy in U.S. Adults Rising

MONDAY, Aug. 14, 2017 (HealthDay News) -- In 2015, an estimated 1.2 percent of the U.S. population reported active or current epilepsy, according to research published in the Aug. 11 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.

Matthew M. Zack, M.D., and Rosemarie Kobau, M.P.H., from the CDC in Atlanta, used national data sources for adults to estimate prevalent cases of active epilepsy overall and by state.

The researchers found that 1.2 percent of the U.S. population reported active epilepsy or current epilepsy in 2015. After accounting for income and age differences by state, the estimated numbers of persons with active epilepsy ranged from 5,900 in Wyoming to 427,700 in California. Increases in the number of persons with active epilepsy were indicated based on National Health Interview Survey data from 2010 to 2015, probably due to population growth.

"Public health practitioners, health care providers, policy makers, epilepsy researchers, and other epilepsy stakeholders, including family members and people with epilepsy, can use these findings to ensure that evidence-based programs meet the complex needs of adults and children with epilepsy and reduce the disparities resulting from it," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths